Autoimmune Disorder
5
2
2
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 5 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Spermatogonial Stem Cell (SSC) Transplant and Testicular Tissue Grafting
A Food Effect and Relative Bioavailability Study of Rilzabrutinib in Healthy Participants
Modelling and Control of Non-invasive Vagus Nerve Stimulation for Autoimmune Diseases (1A)
Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants With Active Rheumatoid Arthritis
Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis